JDP Global latest news on UK Commercial Property
Click here for the latest health news
Collaboration Running Well

Written by JDPGlobal | Friday, 16 December 2005

The UK commercial property market is on a run. Pam Golding Commercial and Athanor International Property Investments have their hands in property investments worth thirty million pounds (GDP) by way of commercial property. The strong possibility of a small investment-high income generative enviroment in the property market of the United Kingdom is being sustained by the present craze for a market favouring commercial properties.

According to a leading industry watchdog, the market did better than in fifteen other major nations the world over. It performed almost double the performance rate of other nations in the commercial property market and four times more on the housing market. This trend has not affected only the property business but also has affected all business in all field of investment. Investors are seeking value in the investments that they intend putting their money in. The collaboration of the above mentioned companies puts them ahead of competition when they attempt to make good business in the area of blue chip commercial properties. The inclusion of Arnold Urson who makes the company's offers even more attractive to the public. He was previously with Accenture. His experience will make the collaboration of the two companies stronger. The Chief Executive Officer of the collaboration said that the actual returns are higher that statistics predict. While the predictions were ten percent, the returns have been anywhere between twenty per cent and fifty percent.

At West End Quay, the latest on the list of top properties to invest in, investors have got a return of thirty percent during a period of only twelve months. Another such case is another building in Colchester, The Lyceum by name, which had its value reset for which its investors got half of the reset value and kept the ownership of the building for it to generate further income for them. Of the latest lot, a building in Cheshire, England was over subscribed. It had an area of four thousand square metres. It was rented out to British Nuclear Fuels Ltd. The present field ventured by the company is buildings mostly in the United Kingdom.

There are plans on the anvil to look beyond the borders of the country. Also to be ventured into by the company is the prospect of offering value creation opportunities as a part of its services through out the continent.

On the things to do list for the collaborative venture of both the companies is to get into Germany and establish a base there. They are starting to further their stake in the UK market. Germany is ripe for the property market. The retail consumption business is heading for a boost because savings now are at a record level. The potential customer too is showing that it will take part if the area shows promise. Loans are available as easily as ever. People, businesses, and the government are all set to start moving forward. Rents too have gone up in particular zones over the previous decade.

© 2010 This content has been exclusively written by JDP Global


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
:: E-commerce project management on international platforms
:: Bringing new and exciting products to the market
:: International business growth
:: Bringing great products to the International market
 
 JDP Updates - case study - 2005 (e-commerce)

Overview
Some of our most challenging projects include sensitive data sites where sound legal advice is a constant, the UK Medix site and the UK Medix plus have been our toughest to date.
Providing online healthcare for patients suffering from Impotence, Obesity and Hairloss. UK Medix has developed into a popular UK Health clinic.
Developing the brand
To compliment UK Medix, we launched UK Medix Plus which includes extra features; forums, daily health tips, an online shopping cart system and a membership based option.
Summary so far
This is a complex platform, enabling qualified UK doctors to communicate with patients and our licensed pharmacists.  Treatments include tamiflu, acomplia, viagra, cialis, levitra, xenical, reductil, uprima & propecia

 

sitemap: home | contact us | about us | portfolio | e-commerce | legal advice | processing | marketing | international trade | login

associated: UK Medix | UK Medix Plus | UK Medix Plus Forum